Percheron Therapeutics
(OTC) ATHJF
Percheron Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$4.55M
Net Income (TTM)
$23.30M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ATHJF News
ATHJF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Percheron Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
4
CEO
James Stuart Garner, PhD, MBA
Website
www.PercheronTx.comHeadquarters
Toorak, VIC 3142, AU
ATHJF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-1%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$2.91M
Operating Income
$11.83M
EBITDA
$11.90M
Operating Cash Flow
$10.12M
Capital Expenditure
$3.61K
Free Cash Flow
$10.12M
Cash & ST Invst.
$11.87M
Total Debt
$39.87K
Percheron Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.77M
+16.5%
Gross Profit
$1.75M
+17.0%
Gross Margin
98.92%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$7.18M
-153.6%
EBITDA
$7.17M
-151.1%
Quarterly Fundamentals
Net Cash
$11.83M
-37.8%
Accounts Receivable
$2.51M
+36.3%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$39.87K
-57.6%
Return on Assets
-1.20%
N/A
Return on Invested Capital
-1.58%
N/A
Free Cash Flow
$5.37M
-27.1%
Operating Cash Flow
$5.37M
-27.3%